SCD, a key enzyme in fatty acid metabolism, has been demonstrated to prevent obesity and diabetes in HFD-fed mice, improving their lipid metabolic status and insulin sensitivity. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.